Market Cap | 6.31B | P/E | 54.83 | EPS this Y | 22.40% | Ern Qtrly Grth | 1.90% |
Income | 79.4M | Forward P/E | 26.38 | EPS next Y | 11.60% | 50D Avg Chg | -20.00% |
Sales | 2.02B | PEG | 2.88 | EPS past 5Y | 0.16% | 200D Avg Chg | -24.00% |
Dividend | N/A | Price/Book | 4.74 | EPS next 5Y | 11.90% | 52W High Chg | -40.00% |
Recommedations | 2.00 | Quick Ratio | 0.98 | Shares Outstanding | 53.47M | 52W Low Chg | 13.00% |
Insider Own | 8.17% | ROA | 3.00% | Shares Float | 44.21M | Beta | 0.98 |
Inst Own | 93.38% | ROE | 5.93% | Shares Shorted/Prior | 2.92M/6.75M | Price | 119.52 |
Gross Margin | 49.28% | Profit Margin | 3.94% | Avg. Volume | 744,135 | Target Price | 155.00 |
Oper. Margin | 5.70% | Earnings Date | Nov 5 | Volume | 873,473 | Change | -1.58% |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Needham | Hold | Sep 25, 24 |
Needham | Hold | Sep 20, 24 |
Piper Sandler | Overweight | Aug 7, 24 |
Needham | Hold | Aug 7, 24 |
Needham | Hold | Jul 9, 24 |
Piper Sandler | Overweight | Jun 3, 24 |
Piper Sandler | Neutral | May 8, 24 |
Needham | Hold | May 8, 24 |
Stifel | Buy | Apr 15, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | May 25 | Buy | 157.5 | 6,365 | 1,002,488 | 366,055 | 05/30/23 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Nov 14 | Buy | 124.3 | 31,994 | 3,976,854 | 39,778 | 11/15/22 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Nov 11 | Buy | 129.28 | 7,784 | 1,006,316 | 7,784 | 11/15/22 |
Mikkelson Adam | Director Director | Jan 24 | Sell | 214.80 | 600 | 128,880 | 1,751 | 01/26/22 |
Mikkelson Adam | Director Director | Jan 10 | Sell | 250.01 | 600 | 150,006 | 2,951 | 01/12/22 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Nov 03 | Sell | 290.17 | 4,373 | 1,268,913 | 612,613 | 11/05/21 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Oct 26 | Sell | 290.63 | 49,785 | 14,469,015 | 30,619 | 10/28/21 |
REYNOLDS CRAIG B | Director Director | Jan 13 | Sell | 279.74 | 10,000 | 2,797,400 | 4,300 | 01/13/21 |
REYNOLDS CRAIG B | Director Director | Jan 13 | Option | 23.04 | 10,000 | 230,400 | 14,300 | 01/13/21 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Jan 11 | Sell | 280.81 | 63,274 | 17,767,972 | 83,807 | 01/11/21 |
Sampath Anand | EVP, Ops & Clinical.. EVP, Ops & Clinical Research | Dec 17 | Option | 26.39 | 30,000 | 791,700 | 28,782 | 12/17/20 |
Sampath Anand | EVP, Ops & Clinical.. EVP, Ops & Clinical Research | Dec 17 | Sell | 265.59 | 30,000 | 7,967,700 | 13,782 | 12/17/20 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Dec 10 | Option | 28.03 | 57,336 | 1,607,128 | 160,606 | 12/10/20 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Dec 07 | Option | 28.03 | 100,000 | 2,803,000 | 170,929 | 12/07/20 |
KIANI JOE E | CEO and Chairman of.. CEO and Chairman of the Board | Dec 07 | Sell | 262.32 | 100,000 | 26,232,000 | 159,241 | 12/07/20 |
Young Micah W | EVP & Chief Financia.. EVP & Chief Financial Officer | Oct 21 | Option | 84.97 | 10,000 | 849,700 | 10,000 | 10/21/20 |
Young Micah W | EVP & Chief Financia.. EVP & Chief Financial Officer | Oct 21 | Sell | 239 | 10,000 | 2,390,000 | 10/21/20 |